Hypertension and mild chronic kidney disease persist following severe haemolytic uraemic syndrome caused by Shiga toxin-producing Escherichia coli O104:H4 in adults

Shiga toxin-producing, enteroaggregative Escherichia coli was responsible for the 2011 outbreak of haemolytic uraemic syndrome (HUS). The present single-centre, observational study describes the 1-year course of the disease with an emphasis on kidney function. Outcome data after 1 year are associate...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nephrology, dialysis, transplantation dialysis, transplantation, 2016-01, Vol.31 (1), p.95-103
Hauptverfasser:	Derad, Inge, Obermann, Birgit, Katalinic, Alexander, Eisemann, Nora, Knobloch, Johannes K-M, Sayk, Friedhelm, Wellhöner, Peter, Lehnert, Hendrik, Solbach, Werner, Süfke, Sven, Steinhoff, Jürgen, Nitschke, Martin
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Anti-Bacterial Agents - therapeutic use Antibodies, Monoclonal, Humanized - therapeutic use Azithromycin - therapeutic use Complement Inactivating Agents - therapeutic use Drug Therapy, Combination Enterohemorrhagic Escherichia coli Escherichia coli Infections - complications Escherichia coli Infections - drug therapy Escherichia coli Infections - microbiology Female Follow-Up Studies Glomerular Filtration Rate Hemolytic-Uremic Syndrome - complications Hemolytic-Uremic Syndrome - drug therapy Hemolytic-Uremic Syndrome - microbiology Humans Hypertension - microbiology Hypertension - prevention & control Male Middle Aged Prospective Studies Renal Insufficiency, Chronic - microbiology Renal Insufficiency, Chronic - prevention & control Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!